statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Latest Ratings for DMTK
 DateFirmActionFromTo Jan 2022Stephens & Co.Initiates Coverage OnOverweight May 2021BTIGInitiates Coverage OnBuy Jan 2021OppenheimerInitiates Coverage OnOutperform
 View...

What Analysts Are Saying About DermTech Stock

DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the special committee of its board...

DermTech to Explore Strategic Alternatives and Implement Restructuring Plan

DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that effective March 27, 2024, the...

DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fortrea (NASDAQ:FTRE  Get Free Report) and DermTech (NASDAQ:DMTK  Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses...

DermTech (NASDAQ:DMTK) vs. Fortrea (NASDAQ:FTRE) Financial Analysis

DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the presentation of two research...

DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology

DermTech (NASDAQ:DMTK  Free Report) had its price objective trimmed by Stephens from $2.50 to $1.50 in a report issued on Tuesday morning, Benzinga reports. The firm currently has an equal...

DermTech (NASDAQ:DMTK) Price Target Lowered to $1.50 at Stephens

Q4 2023 DermTech Inc Earnings Call Transcript

DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its fourth-quarter 2023 financial...

DermTech Reports Fourth-Quarter 2023 Financial Results

DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, will host a conference call and webcast on Thursday...

DermTech Announces Release Date for Fourth-quarter 2023 Financial Results

DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced additional restructuring actions to...

DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations

DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in San Diego, CA.

Volume	168,697.00
52-Wk High	$3.93
52-Wk Low	$0.59

DMTK DermTech Inc

About

Feed

News

Sentiment

Earnings

Fundamentals